Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02953860
Brief Title: Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

First Submitted : November 1, 2016
First Submitted that Met QC Criteria : November 1, 2016
First Posted : November 3, 2016 (Estimate)

Results First Submitted : March 12, 2021
Results First Posted with QC Comments : April 8, 2021
Results First Submitted that Met QC Criteria : April 23, 2021
Results First Posted : May 14, 2021

Last Update Submitted that Met QC Criteria : April 23, 2021
Last Update Posted : May 14, 2021